Find information on Raynaud's Phenomenon diagnosis, including clinical documentation, medical coding, ICD-10 codes I73.0 (Raynaud's syndrome) and I73.8 (other specified peripheral vascular diseases), symptoms, treatment, and healthcare provider resources. Learn about primary and secondary Raynaud's, differential diagnosis, and best practices for accurate medical recordkeeping related to this vasospastic disorder. This resource offers guidance on proper coding and documentation for healthcare professionals dealing with Raynaud's disease.
Also known as
Raynaud's syndrome
Reduced blood flow to fingers and toes, causing numbness and discoloration.
Raynaud's syndrome complicating pregnancy, childbirth and the puerperium
Raynaud's syndrome occurring during or after pregnancy.
Systemic sclerosis
Autoimmune connective tissue disease sometimes associated with Raynaud's.
Other specified effects of reduced temperature
Could be used for Raynaud's triggered by cold exposure if no other code fits.
Patient presents with complaints consistent with Raynaud's phenomenon, including episodic vasospasms in the digits, primarily affecting the fingers and toes. Symptoms include color changes such as pallor, cyanosis, and rubor, accompanied by sensations of coldness, numbness, and tingling. Triggers for these episodes include cold exposure and emotional stress. The patient denies any history of connective tissue disease, secondary Raynaud's syndrome, or other underlying medical conditions. Physical examination reveals normal capillary refill in the absence of vasospastic episodes. Peripheral pulses are palpable and symmetrical. No ulcerations or gangrene are observed. Assessment includes primary Raynaud's phenomenon. Differential diagnosis considered includes secondary Raynaud's phenomenon, acrocyanosis, and peripheral artery disease. Plan includes patient education on avoiding triggering factors such as cold temperatures and stress management techniques. The patient will be instructed on rewarming techniques for acute episodes. Pharmacological interventions, such as calcium channel blockers, are not currently indicated but will be considered if symptoms progress or become severe. Follow-up is recommended to monitor symptom progression and assess for any development of complications. ICD-10 code I73.9 for Raynaud's syndrome is documented. Medical billing codes will be generated based on evaluation and management services provided. This documentation supports the diagnosis and treatment plan for Raynaud's phenomenon.